Ear cleaning is a therapeutic component in the management of otitis externa in dogs. The objectives of this study were to evaluate the in vivo efficacy and safety of a new ear cleanser, Sonotix® against EpiOtic® Advanced for the management of canine otitis externa. Eighteen clients owned dogs with a diagnosis of erythemato-ceruminous or purulent otitis externa were prospectively included and randomized to two treatment group: EpiOtic® Advanced and Sonotix®. Cytology and video-otoscopic examination (erythema, amount of cerumen and thickness and surface of ear canal covered by cerumen) of all affected ears were done at D0, both before (T0) and 30 minutes (T0 + 30 min) after ear cleaning. Then an ear medication was applied (Aurizon®, Vetoquinol). Owners were instructed to clean affected ears daily and apply the ear medication 30 minutes later for 5 days (D1-D5). Dogs were seen again at D6 for cytology and video-otoscopic examination. At T0, no significant differences were found between both ear cleansers groups regarding macroscopic and microscopic scorings. At T0 + 30 min and D6 cytological and video-otoscopic scores were significantly decreased (Wilcoxon test; p < 0.01) compared to baseline in both groups. However, the cleaning activity of Sono-tix® was statistically superior to Epiotic® as evidenced by the median global scores of video-otoscopic examination at T0 + 30 min (Mann Whitney Test, p < 0.01). Effective ear cleaning is an essential part of any treatment scheme because it favours the contact between the ointment and the lining ear epi-How to cite this paper: Marignac68
Introduction
Otitis externa (OE) is a common pruritic and/or painful condition characterized by skin inflammation of the ear canal that can be related to a complex and multifactorial aetiology [1] [2] [3] . Causes of otitis are various, involving primary factors such as hypersensitivities and ectoparasites, predisposing factors are related to ear anatomy and environmental conditions, secondary factors that exacerbate inflammation such as bacterial/fungal infections and perpetuating factors that prevent the resolution of otitis and lead to relapse [1] [3] . Reporting rate from veterinary clinics indicated that canine OE is a very common condition (4% -20%) [4] [5] .
Chronic OE is associated with a thickening of the ear canal walls, stenosis, malfunctioning of secretory system and colonization by pathogenic microorganisms [2] [6] .
Aggregated cerumen, debris and exudates are factors favouring the overgrowth of pathogens such as Staphylococcus pseudintermedius, Pseudomonas aeruginosa and Malassezia pachydermatis [7] [8] [9] [10] . Therefore, the diagnosis OE relies on a clinical history as well as a clinical examination of the ear canal and cytology of the ear exudates [1] [11] [12] .
Ear cleaning is part of routine canine hygiene for many owners [4] [13] . It is frequently used prior to otic ointment application and to maintain a favourable ear environment, especially for dogs with predisposing factors. Treatment of OE is usually local and ear cleansers are often prescribed as the first-line treatment for OE before any medicated topical treatment is applied. The aim of the cleansing agents is to clean the surface of the ear canal lining epidermis, to remove microbes, biofilms, debris and small foreign bodies, to expose the lining of the ear canal to topical therapy and to prevent inactivation of topical therapy [13] . A wide range of ear cleansers with different properties are available on the veterinary market [13] [14] [15] [16] but given the high degree of complexity in the formulation and the limited particularly on its detailed composition, it is difficult for the practitioner to have reliable data to evaluate their properties. In literature, very few in vivo or in vitro studies of ceruminolytic activity of veterinary ear cleaning products have been conducted [17] [18] [19] [20] . In a previous in vitro trial whose aim was to compare the ceruminolytic activity of five commercial ear cleaners on synthetic canine cerumen, the ear solution (Sonotix®, Vetoquinol, Lure, France) containing ethoxydyglycol, isopropyl alcohol, capric glycerides, lipacids, glycerin, thromethamine, polysorbate 80 and calendula had the most effective and rapid ceruminolytic activity of the products tested [17] .
The purpose of this study is to investigate and to compare the safety and the efficacy of a new commercial ear cleaner (Sonotix®, Vetoquinol, Lure, France) in comparison to a commercial canine ear cleaner (EpiOtic® Advanced, Virbac, Carros France) to reduce cerumen accumulation and micro-organisms in the external ear canal of client-owned dogs with spontaneous otitis externa.
Materials & Methods

Overview
Dogs with a visible amount of cerumen and spontaneous otitis externa were prospectively included between December, 14th, 2014 and June, 12th, 2015. The study was conducted in compliance with applicable animal welfare regulations relating to the care and use of animals for scientific purposes, and the study protocol was approved by the relevant institutional Animal Ethics. The study was conducted in accordance with good clinical practice guidelines (GCP) and written informed consent was obtained from the owner of each participating dog. Owners and/or veterinarians were free to withdraw the dog from the study at any time. Owners were given a telephone number in case they had a question or observed an adverse effect. In compliance with GCP, clinicians either hold a French Certificate in Veterinary Dermatology or a Diploma of the European College of Veterinary Dermatology.
Study Design
The study was conducted as a double-blinded, randomized, controlled clinical trial in a teaching veterinary hospital. Each dog ear was considered as the experimental unit and randomization was based on the order of enrolment. The animals were observed twice at one week interval (intended period of study for each enrolled dog was 7 ± 1 day).
Inclusion and Exclusion Criteria
All dogs included were weaned (over 3 months old), client-owned, with clinical signs of otitis externa (including the presence of cerumen in the external ear canal), and without signs of marked and/or generalized skin disease at the time of inclusion (clinician assessment). Dogs with parasitic otitis, otic foreign body, end-stage proliferative ear disease, occlusive masses in the ear canal, ruptured tympanic membrane, autoimmune skin disease, or poor general health were not included in the trial. Dogs requiring a different treatment (product, procedure, frequency) and those showing an aggressive or fearful behaviour during the examination were also not included.
Prohibited Medications and Therapies
Withdrawal times for prohibited medications were as follows: long-acting corticoids, 3 weeks; oral corticoids, 8 days; antihistamines, 3 days; oral antibacterial/antifungal agents, 8 days. All current treatments, including those eventually administered during the study, were noted in the concomitant table in compliance with the guidelines. 
Drug Administration
OE treatment
For the treatment of otitis, owners were instructed to administrate daily 10 drops of Aurizon® (Vetoquinol, Lure, France) 30 minutes after ear cleaning. Table 1 and Table 2 . Scorings were adjusted during a preliminary study on Beagle dogs (data not shown). Each ear was scored separately.
Study Schedule and Variable Measures
Otic exudate was collected by means of a cotton swab and the tip of the swab Open Journal of Veterinary Medicine was then rolled onto a clean microscope slide. After drying, the slide was stained with a quick staining kit (RAL 555) and scored following a semi-quantitative method (range 0 -4) with a total score of 0 to 20.
The erythema, the amount and thickness of cerumen and surface of external ear canal covered by ear wax were assessed by a video-otoscopic examination of each ear canal with individual scores. A four-point-scale and a five-point-scale were used to score the erythema and the cerumen, respectively, with a total score of 0 to 11.
According to severity each video-otoscopic and cytological slides were evaluated blindly by one clinician. At the end of the study, each video-otoscopic and each cytological slide were blindly assessed by one clinician.
Both ears video-otoscopy and cytology were performed prior (T0) and 30 minutes (T0 + 30 min) after the first ear cleaning at day 0 (D0), and during the follow-up visit scheduled on day 6. Ear cleaning was performed by the clinician at D0 and subsequently done daily by the owner until day 5 (D5). 
Efficacy Outcome Measures
Video-otoscopic and cytological scores were used to assess the primary efficacy in this study: baseline score (T0 on D0) and scoring at each time point (T0 + 30 min on D0 and D6).
Any abnormal clinical signs reported by the owner or identified by the investigator were recorded in the case report form.
Data Analysis
Dogs with one or major protocol deviations that affected the integrity of efficacy data were excluded from the analysis.
Qualitative parameters (sex, type of otitis, otitis history, number of adverse 
Results
Population study for EpiOtic® Advanced ( Table 3 ). The important reductions in yeast, cocci, and rod-shaped organism counts were demonstrated in smears 30 minutes after the cleansing in both groups and at D6 (Figure 1 ). The median global scores of video-otoscopic examination, as shown in Table   3 and Figure 2 , was 6 at T0 for both groups, 3 for Sonotix® and 4 for EpiOtic® Advanced at T0 + 30 min and 2 at D6 for both group.
30 minutes after the cleaning of ears there was a significant (P < 0.01) decrease of the amount of cerumen in vertical and horizontal ear canal from baseline.
Intra-group comparison shows a significant difference (p value < 0.01) between T0 (Sonotix®: 6 EpiOtic® Advanced: 6) and T0 + 30 min (Sonotix®: 3, EpiOtic® Advanced: 4) and between T0 and D6 (Sonotix®: 2, EpiOtic® Advanced: 2).
Inter-group comparison shows a significant difference at T0 + 30 min (p < 0.01) between Sonotix® (median score: 3) and EpiOtic® Advanced (median score: 4) ( Figure 3 ).
Discussion
In the present study, both ear cleansers reduced bacterial and yeast overgrowth This suggests that Sonotix® has a faster and more efficient action in cerumen removal. This enhanced ceruminolytic activity had also been demonstrated in an in vitro trial [17] . In that study, which the aim was to compare the ceruminolytic activity of five commercial ear cleaners on synthetic canine cerumen, the ear solution (Sonotix®, Vetoquinol, Lure, France) had the most effective and rapid ceruminolytic activity of the products tested. This fastest ceruminolytic activity could be in part explained by ingredient composition comprising three cerumenolytic agents acting synergistically. Ethoxydiglycol (protic solvent) and iso- Cytological and clinical improvement, compared to T0, was also seen at D6 but no difference was seen between Sonotix® and EpiOtic® Advanced. As these dogs had clinical OE, for ethical reasons they were not treated with ear cleaner only.
Both groups were prescribed daily application of Aurizon®, a product known to have strong anti-inflammatory, antibacterial and anti-yeast activity.
The video-otoscopic scoring used in this study was developed to assess the cerumen burden and erythema as opposed to other published scorings developed to globally assess otitis externa severity [21] . In order to reduce inter clinician bias and before and after application bias, all video-otoscopy and cytology were evaluated by an experienced dermatologist (Dip. ECVD).
In healthy ear, the removal of cerumen and debris from the external ear canal is primarily achieved by epithelial migration. This physiologic process allows cerumen transport away from the tympanic membrane and towards the opening at the distal end of the ear canal. Recently this process has been demonstrated to follow both radial and centrifugal patterns in the dog [22] . While it is commonly accepted ear cleaning is not necessary for healthy ears, it has several benefits in many conditions as those in which epithelial migration is impaired. Failure of epithelial migration may result in the accumulation of flakes of skin in the ear canal and soft wax plugs. Furthermore, the migratory process is a key factor in the repair of spontaneous TM perforations and post-operative TM incisions Effective ear cleaning is an essential part of any treatment scheme because it favours the contact between the ointment and the lining ear epidermis and speeds resolution by the removal of cerumen, microbial organisms, cellular debris and free fatty acids and prevents potential inactivation of topical therapy by purulent material [4] [13] . Our results comfort the common habit of prescribing a regular ear cleaner as a component in the management of OE in dogs.
A wide range of ear cleansing preparations and procedures aimed to remove exudates and ceruminous debris have become very popular in veterinary practice. Knowledge of their properties helps to choose the best available product for specific clinical situations. Choosing the most appropriate product is akin to selecting a shampoo. It depends on the individual patient and it is of crucial importance to fully evaluate the primary, predisposing and perpetuating factors, the type otitis and the chosen topical therapy.
Oil-based ear cleaners, compared to those containing strong ceruminolytics, tend to be much gentler as they loosen wax, rather than disrupt it, but they do leave a residue in the canal. Moreover, it is questionable if they are of many benefits in ears with a purulent discharge. A cleaner with aqueous properties would be more indicated in a purulent otitis [23] .
Knowledge of ear cleaner's pH it is also very important, especially if they are associated with topical antibiotics. Even if the antimicrobial activity of certain Open Journal of Veterinary Medicine ear cleaners has been shown to be associated with a low pH, acid cleaners may inactive some antimicrobials (especially aminoglycosides and fluoroquinolones) [24] . In the present study, a complete clinical and microbiological resolution was observed at D6 suggesting that the concomitant use of Sonotix®, didn't interfere with the activity of Aurizon® or didn't inactivate the antimicrobial contained in it. Further studies to directly prove it (synergy in vitro test) are however necessary.
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